SG's earnings recovery gains legs as the execution of the strategic plan unfolds
15/04/24 -"We now factor a stronger recovery into our 2024 (+16%) and 2025 (+15%) EPS projections as we see a higher prospect of recovery for SG. Our 2024 upgrade comes on the back of higher revenue (+2%), ..."
Pages
77
Language
English
Published on
15/04/24
You may also be interested by these reports :
24/09/26
The MPS CEO’s presentation at the BofA conference helped clarify the project. It is not a defensive project. Execution risk appears limited. The ...
23/09/26
Following the CMD, we have updated our projections to reflect both the new inputs provided by the management as well as the slightly downgraded macro ...
21/09/26
SocGen’s 2026 CMD “enhances” its turnaround: 3% revenue CAGR, absolute cost cut (€16.3bn cost target in 2029), C/I ratio below 55%, and 13-14% ROTE ...
16/09/26
Reading European equities earnings dynamic, i.e. revisions, remains a brain torturing exercise for anyone wondering where the 2026 earnings growth at ...